Novo Seen Missing Target of 40 Million Diabetics Treated by 2020

excluded North America, Europe, Japan and South Korea — would predominantly drive the growth in the number of patients it reaches, Novo said at that time.Novo provided treatments to about 28 million…

View this article online at Bloomberg
Source: Bloomberg climate change